Matches in Nanopublications for { ?s ?p "[PEG-ADA is a long-circulating form of adenosine deaminase (ADA) that has been in use for > 8 years as replacement therapy for severe combined immunodeficiency disease due to ADA deficiency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP695006.RAa8Wg7zZyoJOuROEPhF7zSCpmNA1ZC_e4WsV-7JauF9I130_assertion description "[PEG-ADA is a long-circulating form of adenosine deaminase (ADA) that has been in use for > 8 years as replacement therapy for severe combined immunodeficiency disease due to ADA deficiency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP695006.RAa8Wg7zZyoJOuROEPhF7zSCpmNA1ZC_e4WsV-7JauF9I130_provenance.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion description "[PEG-ADA is a long-circulating form of adenosine deaminase (ADA) that has been in use for > 8 years as replacement therapy for severe combined immunodeficiency disease due to ADA deficiency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.